Catabasis Pharmaceuticals (CATB)

[murocman]

And what report would that be. If you look waaaay back to the beginning of Feb and take a look at the chart, you'll notice the stock was at $4. Then came this event called a data release and their trial was a FAILURE! My only question was what makes anyone think that anything has changed to have any hope of the stock ever getting back to that level let alone warranting the current valuation, because I don't see it.

Good luck